Tempest Therapeutics Inc
NASDAQ:TPST
During the last 3 months Tempest Therapeutics Inc insiders have not bought any shares, and have not sold any shares. The stock price has dropped by 23% over this period (open performance analysis).
The last transaction was made on
Aug 12, 2024
by
Versant Ventures Iv, Llc
, who
sold
427k USD
worth of 
TPST shares.
During the last 3 months Tempest Therapeutics Inc insiders have not bought any shares, and have not sold any shares. The stock price has dropped by 23% over this period (open performance analysis).
The last transaction was made on
Aug 12, 2024
by
Versant Ventures Iv, Llc
, who
sold
427k USD
worth of TPST shares.
Tempest Therapeutics Inc
Glance View
Tempest Therapeutics, Inc.is a clinical-stage biotechnology company. The company is headquartered in South San Francisco, California and currently employs 17 full-time employees. The company went IPO on 2012-10-04. The firm is focused on developing therapeutics that combine both targeted and immune-mediated mechanisms to treat a wide range of tumors. The Company’s two clinical programs include TPST-1495 and TPST-1120. TPST-1120 is a selective antagonist of peroxisome proliferator-activated receptor. TPST-1120 is in Phase I and II trials in solid tumors, including a global randomized Phase Ib/II trial in combination with the standard-of-care first-line regimen of atezolizumab and bevacizumab in patients with advanced or metastatic hepatocellular carcinoma (HCC). TPST-1495, is a dual antagonist of EP2 and EP4, receptors of prostaglandin E2, and is in a Phase I monotherapy and combination trial in solid tumors.
What is Insider Trading?
Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.
While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.
Why is Insider Trading Important?
It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.
However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.
Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
